PROCEPT BioRobotics officer reports initial share holdings
PROCEPT BioRobotics Corp reported initial insider holdings for Chief Strategy and Marketing Officer Pooja Sharma.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
PROCEPT BioRobotics Corp reported initial insider holdings for Chief Strategy and Marketing Officer Pooja Sharma. She beneficially owns 87,559 shares of Common Stock directly, including restricted stock units that vest over time as long as she continues as a service provider.
She also holds stock options covering 29,615 shares of Common Stock at an exercise price of $25.35 per share, expiring on March 4, 2036, and options for 85,929 shares at an exercise price of $31.92 per share, expiring on November 6, 2035. These options vest gradually over several years, contingent on continued employment.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Sharma Pooja
Role
Chief Strat/Marketing Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 115,544 contracts (Direct);
Common Stock — 87,559 shares (Direct)
Footnotes (3)
- F1. These securities include restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on the anniversary of the grant date, with one-twelfth of the remaining RSUs shall vest on each quarter thereafter, subject to the Reporting Person continuing as a service provider through such date.
- F2. The Stock Option was granted on November 7, 2025, and one-quarter of the shares subject to the Stock Option shall vest on November 7, 2026, with the remaining vesting monthly thereafter over 36 months, subject to the Reporting Person continuing as a service provider through such date.
- F3. The Stock Option was granted on March 5, 2026, and 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.
Key Figures
Common shares owned: 87,559 shares
Option grant 1 exercise price: $25.35 per share
Option grant 1 underlying shares: 29,615 shares
+4 more
7 metrics
Common shares owned
87,559 shares
Direct beneficial ownership as of Form 3
Option grant 1 exercise price
$25.35 per share
Stock Option (Right to Buy), expires March 4, 2036
Option grant 1 underlying shares
29,615 shares
Underlying Common Stock for $25.35 options
Option grant 2 exercise price
$31.92 per share
Stock Option (Right to Buy), expires November 6, 2035
Option grant 2 underlying shares
85,929 shares
Underlying Common Stock for $31.92 options
Option grant 1 expiration
March 4, 2036
Expiration date for $25.35 options
Option grant 2 expiration
November 6, 2035
Expiration date for $31.92 options
Key Terms
restricted stock units (RSUs), Stock Option (Right to Buy, vesting, exercise price, +1 more
5 terms
restricted stock units (RSUs) financial
"These securities include restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Stock Option (Right to Buy financial
"security_title: Stock Option (Right to Buy), underlying security Common Stock with specified exercise prices and expirations."
vesting financial
"One-quarter of the RSUs shall vest on the anniversary of the grant date, with remaining RSUs vesting quarterly thereafter."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"Stock options have an exercise price of 25.3500 and 31.9200 per share of Common Stock."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"The stock options list expiration dates of 2036-03-04 and 2035-11-06 in the filing data."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the PROCEPT BioRobotics (PRCT) Form 3 filing show for Pooja Sharma?
The Form 3 shows that Chief Strategy and Marketing Officer Pooja Sharma beneficially owns 87,559 PROCEPT BioRobotics common shares and holds multiple stock option awards that vest over time, reflecting her current equity stake at the time of becoming a reporting insider.
What stock options does Pooja Sharma report in the PROCEPT BioRobotics (PRCT) Form 3?
She reports options for 29,615 shares at a $25.35 exercise price expiring March 4, 2036, and options for 85,929 shares at a $31.92 exercise price expiring November 6, 2035. Both grants vest gradually over several years, subject to continued employment.
How do Pooja Sharma’s stock options in PROCEPT BioRobotics (PRCT) vest?
One option grant vests with one-quarter of shares on November 7, 2026, and the remainder monthly over 36 months. Another vests 1/48th of the shares monthly from March 5, 2026, with all vesting contingent on her continued employment or service.
Does the PROCEPT BioRobotics (PRCT) Form 3 indicate any recent insider buying or selling?
The Form 3 is an initial ownership report and does not show any explicit insider purchases or sales. It instead lists Pooja Sharma’s existing common stock, restricted stock units, and stock options as of when she became a reporting insider.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates